NIH-funded research R21 grant

Understanding how gut bacteria produce important proteins for survival

Official title: Bacteroides use a novel N-acyltransferase for lipoprotein synthesis and survival

Funded at University of Michigan at Ann Arbor · NIH-11109401 · Data updated 2026-11-12

This study is looking at how certain friendly gut bacteria, called Bacteroides, make special proteins that help them live and work with our bodies, and it could help us learn more about keeping our gut healthy.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJune 6, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$186,768
NIH project number5R21AI180287-02
Project IDNIH-11109401 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with gut health issues or those interested in the role of gut bacteria in overall health.

Less likely to help

Patients who do not have any gastrointestinal conditions or are not interested in gut microbiome research may not benefit from this research.

What this research studies

This research investigates how certain gut bacteria, specifically Bacteroides, synthesize lipoproteins that are crucial for their survival and interaction with the human host. The study focuses on a specific enzyme, Bacteroides Lipoprotein N-acyltransferase (BLnt), which plays a key role in modifying these lipoproteins. By using genetic screening techniques, the researchers aim to uncover the mechanisms behind lipoprotein production and how these bacteria adapt to their environment in the gut. This knowledge could lead to better understanding of gut health and bacterial behavior.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of gut bacteria's role in health and disease, potentially leading to new therapeutic strategies.

How similar studies have gone: Other research has shown promising results in understanding bacterial interactions in the gut, making this approach both relevant and potentially impactful.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Koropatkin, Nicole M — University of Michigan at Ann Arbor
  • Study coordinator: Koropatkin, Nicole M

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.